Pace of cancer drug reimbursement varies wildly across Europe
Researchers have found that some European countries take more than twice as long as others to reach health technology assessment...
Trending:
-
![appeal the Pfizer]()
ACCC’s appeal over Pfizer Australia ruling on Lipitor dismissed
-
![Imraldi]()
Samsung Bioepis’ biosimilar to Humira launched in the EU
-
![employing AI to improve drug discovery]()
Verge Genomics: employing AI to improve drug discovery
-
![Roche]()
Roche reports sales growth as new drugs ease pressure from biosimilar competition
-
![AstraZeneca will continue its investment freeze in UK due to Brexit uncertainty]()
AstraZeneca to continue UK investment freeze due to Brexit uncertainty
-
![Humira]()
AbbVie and Sandoz resolve Humira biosimilar patent dispute
Expert commentary & analysis from GlobalData
Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth
NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial
Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders
AZ’s Brexit freeze will be short-term, but UK pharma’s future remains unclear
Most Read
Company releases
Italvacuum to Attend PHARMTECH
Italvacuum has announced it is going to participate at PHARMTECH, in Moscow, Russia.
Emisphere’s Technology Supports Novo Nordisk’s Oral Semaglutide
Complimentary Human Error Prevention Workshop
NSF International Pharma Biotech has announced a focused, challenging workshop aimed to improve your understanding of human error.
KUBio™ – The Proven Response for Rapid Biomanufacturing
Product Serialisation for Software and Hardware
CPL is serialisation-ready, in compliance with the Drug Quality Security Act (DQSA).
Company whitepapers
The Buyer’s Guide to Real-Time Temperature Monitoring
TSSThe Future of the Pharmaceutical Industry
NSF International, Pharma BiotechEligen® Technology Mechanism of Action
Emisphere TechnologiesB2G Life Sciences – Building Bridges and Gateways
B2G Life SciencesQualification of Powdered Gelatin Agar by NIR Spectroscopy
ABB AnalyticalFlexible Drug Containers for Parenteral Drugs
Weibel CDSDetermination of Absorption of Isopropyl Myristate in Processing Equipment and Packaging Material by Liquid Extraction and Gas Chromatography
CPLCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at its site in Vienna, Austria.
Lonza’s Ibex Biomanufacturing Complex in Visp, Switzerland
MSD’s Biologics Manufacturing Facility, Swords, Ireland
Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
BeiGene Biologics Manufacturing Facility, Guangzhou
Clinical Trials
Sanofi’s Dupixent meets Phase III trial endpoints for rhinosinusitis
Sanofi has reported positive results from two Phase III clinical trials for its Dupixent drug in adults with inadequately controlled chronic rhinosinusitis with nasal polyps...
UCLH initiates new trial for Alzheimer’s treatment in UK
Biogen reports interim results from Spinraza’s NURTURE study
September’s top news stories
Eisai and Bial report new clinical practice data for Zebinix
Drug Development
SQZ Biotech signs up to $1bn immuno-oncology deal with Roche
Cell therapy company SQZ Biotechnologies has expanded its deal worth up to $1bn with Roche for the development and commercialisation of immune-oncology products.
Immugenyx and Janssen to develop SLE model for drug development
Allele Biotechnology gets NIH grant to develop sepsis therapies
Otsuka expands digital medicines alliance with Proteus Digital
BTG licenses ovarian cancer candidate to Carrick Therapeutics
Market Data
Pace of cancer drug reimbursement varies wildly across Europe
Researchers have found that some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions about reimbursing new...
Deals this week: Eisai Pharmaceutical, Abbvie, Otsuka
Deals this week: Emergent BioSolutions, Pediapharm, Adynxx
Novartis to acquire US cancer drug developer Endocyte for $2.1bn
Takeda gets Japanese approval for $62bn Shire acquisition
Technology
Otsuka expands digital medicines alliance with Proteus Digital
Otsuka Pharmaceutical has expanded its global collaboration agreement with Proteus Digital Health for advancing a portfolio of digital medicines and care models to help patients...
Sandoz launches second Healthcare Access Challenge
Hong Kong researchers create tiny soft robot for drug delivery
Innovate UK funds AI drug discovery platform
Pharma Technology Focus – Issue 75